As cancer rates continue to rise, patients increasingly bear the brunt of both the financial and emotional costs related to their diagnosis. In an effort to combat America’s cancer cost crisis, NuView Life Sciences is developing a new technology, NV-VPAC1, that can help ensure accurate diagnosis to lower costs for patients, families, insurance companies, and government-sponsored healthcare programs, like Medicare.
(PRWeb July 10, 2017)
Read the full story at http://www.prweb.com/releases/2017/07/prweb14492314.htm
For more information, please visit
http://www.prweb.com/releases/2017/07/prweb14492314.htm